Clinical Trial Update: Oncoxin® and Quality of Life in Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing Oncoxin’s impact on quality of life in cancer patients; completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• ONCOXIN

Snippet

Sponsor: Catalysis SL | Conditions: Gastric Cancer Stage II, Non-small Cell Lung Cancer Stage II | Phase 4 | Status: COMPLETED